PXL/HO/Cir-037/2026-27                                                                                          Date: 11.07.2026

Hyderabad

Subject: Invitation to Participate in and Sponsor the Global Drug Regulatory Conclave (GDRC) 2026 (30–31 July 2026, Bharat Mandapam, New Delhi)

Dear Member,

Greetings from the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL).

We are pleased to inform you that the Global Drug Regulatory Conclave (GDRC) 2026 will be held on 30–31 July 2026 at Bharat Mandapam, New Delhi. The Conclave is being jointly organised by the Central Drugs Standard Control Organisation (CDSCO), Ministry of Health & Family Welfare, Government of India, and the Pharmaceuticals Export Promotion Council of India (PHARMEXCIL), with the support of the Ministry of Commerce & Industry, Government of India.

The Global Drug Regulatory Conclave (GDRC) 2026 is India's premier international platform dedicated to pharmaceutical regulatory cooperation. The Conclave will bring together Heads of National Drug Regulatory Authorities, senior regulatory officials, policymakers, international organisations, procurement agencies, industry leaders, and healthcare stakeholders from across the world to deliberate on key issues relating to pharmaceutical regulation, regulatory convergence, quality assurance, innovation, market access, and global public health.

The Conclave presents an exceptional opportunity for the Indian pharmaceutical industry to engage directly with senior drug regulators from major international markets, gain insights into evolving global regulatory frameworks, showcase India's strengths in pharmaceutical manufacturing and regulatory compliance, and strengthen partnerships with key international stakeholders. Participation in GDRC 2026 will enable companies to enhance their global visibility and demonstrate their commitment to quality, innovation, and regulatory excellence.

PHARMEXCIL invites all member companies to participate in this landmark event by nominating their senior representatives from Regulatory Affairs, Quality Assurance, International Business, Research & Development, Manufacturing, and Corporate Leadership.

Following are the conclave registration charges :

P.S:Online registration will remain open until 26 July 2026. On-site registration will also be available at the venue on 30 July 2026.

Registration Portal : https://india-gdrc.com/registration

To provide enhanced visibility and engagement opportunities, PHARMEXCIL has also developed a range of attractive sponsorship packages offering exclusive branding, networking, and promotional benefits throughout the Conclave.

The detailed conclave agenda and Sponsorship Brochure are enclosed for your kind consideration. We cordially invite your esteemed organisation to associate with this prestigious international event by selecting a suitable sponsorship category and becoming a valued partner of GDRC 2026.

Companies interested in sponsorship are requested to convey their confirmation at the earliest to facilitate branding and promotional activities.

We look forward to your active participation and valued support in making the Global Drug Regulatory Conclave (GDRC) 2026 a landmark international event and a resounding success.

For more information kindly contact at Email id : rodelhi@pharmexcil.com, Tel : 011 - 45062550

With warm regards,

Raja Bhanu
Director General

encl:Agenda and sponsorship opportunities